A pilot study investigating the effects of apixaban in patients with chronic disseminated intravascular coagulation (DIC)
Not Applicable
- Conditions
- Chronic Disseminated Intravascular Coagulation(Chronic DIC)
- Registration Number
- JPRN-UMIN000027469
- Lead Sponsor
- Aichi Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients with a history or present illness of severe allergy to a drug 2 Patients with severe renal disorder (< CLcr 30mL/min) 3 Patients whom the study drug might induce to bleed 4 Patients believed to die early even if they recovered from DIC, making it difficult to ensure a sufficient period of administration of the study drug and to obtain data on the efficacy and safety 5 Pregnant women, nursing mothers or possibly pregnant women 6 Patients whom the investigator considers to be unsuitable for participation in the study 7 Patients with severe hepatic disorder (< CLcr 30mL/min) 8 Patients with administration of other anticoagulants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of DIC score
- Secondary Outcome Measures
Name Time Method Adverse event with apixaban (bleeding etc) Drug compliance